ES484167A1 - Un procedimiento para preparar 9-(hidroxialcohil)-purinas - Google Patents

Un procedimiento para preparar 9-(hidroxialcohil)-purinas

Info

Publication number
ES484167A1
ES484167A1 ES484167A ES484167A ES484167A1 ES 484167 A1 ES484167 A1 ES 484167A1 ES 484167 A ES484167 A ES 484167A ES 484167 A ES484167 A ES 484167A ES 484167 A1 ES484167 A1 ES 484167A1
Authority
ES
Spain
Prior art keywords
complexes
activity
purines
hydroxyalkyl
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES484167A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
NEWPORT PHARMACEUTICALS
Institute for Cancer Research
Original Assignee
Institute of Cancer Research
NEWPORT PHARMACEUTICALS
Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research, NEWPORT PHARMACEUTICALS, Institute for Cancer Research filed Critical Institute of Cancer Research
Publication of ES484167A1 publication Critical patent/ES484167A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un procedimiento para preparar un compuesto de la fórmula **( formula-01)** en donde X es OH, NH2, SH, OR O SR (donde R es alcohilo de 1 a 4 átomos de carbono o bencilo), R1 es H alcohilo de 1 a 8 átomos de carbono, R 2 es H o metilo, y es la sal de una amina de la formula.**( formula-02)** en donde R3 y R4 son alcohilo inferior, n es un numero entero de 2 a 4 y en donde z es un número de 1 a 10 con ácido p- acetamidobenzoico, que comprende hacer reaccionar un compuesto de la fórmula: **( formula-03)** con 1 a 10 moles de la sal Y.
ES484167A 1978-09-15 1979-09-14 Un procedimiento para preparar 9-(hidroxialcohil)-purinas Expired ES484167A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines

Publications (1)

Publication Number Publication Date
ES484167A1 true ES484167A1 (es) 1980-09-01

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES484167A Expired ES484167A1 (es) 1978-09-15 1979-09-14 Un procedimiento para preparar 9-(hidroxialcohil)-purinas

Country Status (27)

Country Link
US (1) US4221909A (es)
EP (1) EP0009154B1 (es)
JP (1) JPS5547683A (es)
KR (1) KR840000552A (es)
AT (1) ATE1949T1 (es)
AU (1) AU527851B2 (es)
CA (1) CA1122217A (es)
CS (1) CS251060B2 (es)
DD (1) DD146049A5 (es)
DE (1) DE2964211D1 (es)
DK (1) DK149857C (es)
ES (1) ES484167A1 (es)
FI (1) FI68234C (es)
GR (1) GR74076B (es)
HU (1) HU182544B (es)
IE (1) IE48827B1 (es)
IL (1) IL58087A (es)
IN (1) IN153099B (es)
MX (1) MX6521E (es)
NO (1) NO152445C (es)
NZ (1) NZ191483A (es)
PH (1) PH16315A (es)
PL (2) PL124515B1 (es)
PT (1) PT70180A (es)
RO (1) RO77565A (es)
YU (1) YU41884B (es)
ZA (1) ZA793973B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
JPH10504814A (ja) 1994-07-25 1998-05-12 ジェイ． グラスキー，アルヴィン 一酸化炭素依存性グアニリルシクラーゼ修飾因子
AU5522996A (en) * 1996-02-12 1997-08-28 Cypros Pharmaceutical Corporation Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
DK1790344T3 (da) 2000-07-07 2011-05-02 Spectrum Pharmaceuticals Inc Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Also Published As

Publication number Publication date
NO792792L (no) 1980-03-18
IL58087A (en) 1983-03-31
IN153099B (es) 1984-06-02
ZA793973B (en) 1980-09-24
JPH031309B2 (es) 1991-01-10
FI68234C (fi) 1985-08-12
NZ191483A (en) 1983-06-14
HU182544B (en) 1984-02-28
FI68234B (fi) 1985-04-30
YU224579A (en) 1983-12-31
PL119685B1 (en) 1982-01-30
DE2964211D1 (en) 1983-01-13
PL124515B1 (en) 1983-01-31
NO152445C (no) 1985-10-02
EP0009154B1 (en) 1982-12-08
NO152445B (no) 1985-06-24
KR840000552A (ko) 1984-02-25
FI792849A (fi) 1980-03-16
ATE1949T1 (de) 1982-12-15
JPS5547683A (en) 1980-04-04
RO77565A (ro) 1981-11-04
MX6521E (es) 1985-06-27
DK385679A (da) 1980-03-16
YU41884B (en) 1988-02-29
CA1122217A (en) 1982-04-20
DK149857C (da) 1987-03-02
PH16315A (en) 1983-09-05
EP0009154A1 (en) 1980-04-02
IE791753L (en) 1980-03-15
AU527851B2 (en) 1983-03-24
AU5055779A (en) 1980-03-20
CS251060B2 (en) 1987-06-11
PL218317A1 (es) 1980-06-16
DK149857B (da) 1986-10-13
GR74076B (es) 1984-06-06
PT70180A (en) 1979-10-01
DD146049A5 (de) 1981-01-21
IE48827B1 (en) 1985-05-29
US4221909A (en) 1980-09-09

Similar Documents

Publication Publication Date Title
ES484167A1 (es) Un procedimiento para preparar 9-(hidroxialcohil)-purinas
US4302465B1 (es)
ES484168A1 (es) Un procedimiento para preparar 9-(hidroxialcohil)-purinas
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
ES8502703A1 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
GB1024484A (en) Improvements in and relating to rubber compositions
HU901193D0 (en) Process for protection against phytopathogenic bacteria using phosphonic acid derivatives
IL73257A0 (en) Quinoline derivatives,their preparation and their use for the protection of plants
ES478384A1 (es) Un procedimiento para la obtencion de un compuesto de bici- clooctano.
EP0047405A3 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
ES476645A1 (es) Procedimiento para la obtencion de derivados aminados de pi-razol (1,5-a)s troazina.
ES8201944A1 (es) Un metodo para impartir una propiedad antiestatica a la ropa
ES8206434A1 (es) Procedimiento para la preparacion de composiciones de sales amonicas cuaternarias para el tratamiento de textiles
JPS5610199A (en) Novel phosphonoformic acid hydrazide compound
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
MY101628A (en) Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them.
GB1249167A (en) 2-phenyliminopyrrolidines
ES456925A1 (es) Procedimiento para preparar esteres de acido n,n-dimetil-o- (imidazol (5) il)-carbamico.
JPS5636414A (en) Anticonvulsant agent containing omega-aminoalkoxystilbene or its acid addition salt as active constituent
ES8704175A1 (es) Un procedimiento para la preparacion de derivados de benzopirano (2,3-d) triazol.
JPS5634688A (en) Preparation of cephapirin

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506